Delcath Systems Announces Presentation at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright

NEXT STORY
‘Absorbable’ Surgical Sutures to Witness Rapid Adoption, Key Market Players Focus on Competitive Pricing Strategies for Extended Outreach: Fact.MR
PREV STORY
Media Statement Veyonda® Enhances Radiotherapy in Prostate Cancer Treatment Further Promising Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genmab Announces Abstracts Evaluating Products in Pipeline, Portfolio to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress

author_avatar
NASDAQ Market News

Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)

author_avatar
NASDAQ Market News

Press release Biocartis Group NV: Invitation to the Extraordinary Shareholders’ Meeting

author_avatar
NASDAQ Market News